[Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
D000600:Amino Acids, Dicarboxylic / Q000008:administration & dosage / Q000627:therapeutic use; D000641:Ammonia / Q000097:blood* / Q000506:poisoning; D000818:Animals; D004341:Drug Evaluation; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007656:Ketoglutaric Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009952:Ornithine / Q000008:administration & dosage / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy; D051381:Rats
D000600:Amino Acids, Dicarboxylic; D007656:Ketoglutaric Acids; D000641:Ammonia; D009952:Ornithine
Therapie experimenteller und klinischer Hyperammonämien mit Ornithin-alpha-Ketoglutarat.